New drug duo takes on advanced cancers
Disease control
Recruiting now
This study tests a new drug called FL115 combined with an immunotherapy (PD-1 blocker) in 130 people with advanced solid tumors that have not responded to standard treatments. The trial has two phases: first to find the safest dose, then to see how well the combo works against di…
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Forlong Biotechnology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC